Fortune » - Fortune

As U.S. firms scrap diversity targets, the CEO behind Ozempic and Wegovy took a pay cut for missing them

Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI targets.

Feb 12, 2025 - 12:47
 0
As U.S. firms scrap diversity targets, the CEO behind Ozempic and Wegovy took a pay cut for missing them
Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI targets. Read More
Read More

Tags:

Previous Article

Baidu CEO defends heavy AI investments as competition heats up and Apple reporte...

Next Article

CVS’s stock surges after profit beats by widest margin in more than 4 years

Related Posts

The White House banned an Associated Press reporter because the news agency hasn’t changed its style guide for ‘Gulf of Mexico.’ Experts say the move ‘plainly violates the First Amendment’

The White House banned an Associated Press reporter bec...

Feb 12, 2025  0

More than 8000 family offices are revolutionizing wealth management. Are you rich enough to start one?

More than 8000 family offices are revolutionizing wealt...

Feb 12, 2025  0

DOGE looks to shrink the federal workforce by making buildings and commutes ‘so crappy’ that employees will quit, report says

DOGE looks to shrink the federal workforce by making bu...

Feb 9, 2025  0